Overview

Evaluating the Need for Pneumatic Compression Devices

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:
0

Participant gender:
All

Summary

For patients undergoing total hip and knee arthroplasty, does the use of Aspirin alone compared to using Aspirin along with a mobile compression device provide equivocal results for preventing Deep Vein Thrombosis (DVT) and pulmonary embolism (PE) after total joint arthroplasty? The investigator will evaluate the prevention of DVT/PE after total hip and knee arthroplasty will be evaluated to see if there is a decreased risk of bleeding while continuing to prevent thromboembolic disease. The equivalency of using the mobile compression devices with aspirin compared to aspirin alone in patients undergoing total hip and knee arthroplasty will be evaluated. A previous study has shown that patient compliance with the pneumatic compression device is less than 80%.

Phase:

N/A

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

West Virginia University

Treatments:

Aspirin

Criteria

Inclusion Criteria:

1. All patients, 18+ years of age, scheduled at WVU Medicine Center for Joint Replacement
for a History and Physical visit to undergo a total hip or knee surgery.

2. Primary replacements and revisions.

3. Weight bearing as tolerated postoperatively.

Exclusion Criteria:

1. History of DVT/PE

2. History of hypercoagulable disorder

3. Currently on other blood thinning medication with the exception of aspirin (Plavix,
Coumadin, xarelto, pradaxa, lovenox, heparin, other Factor Xa inhibitors).

4. Patients less than 18 years of age.